GLOW is a combined research peptide blend containing three extensively studied regenerative compounds in one vial, totalling 70 mg of active peptide content:
- GHK-Cu – 50 mg
- BPC-157 – 10 mg
- TB-500 (Thymosin Beta-4 fragment) – 10 mg
Each component has an independent research history: GHK-Cu is studied for collagen synthesis and extracellular matrix remodelling, BPC-157 for cytoprotective and angiogenic properties in gastrointestinal and musculoskeletal models, and TB-500 for its role in actin regulation and cell migration during tissue repair. Combining all three into one formulation is intended to simplify multi-compound research protocols studying synergistic regenerative pathways.
